CAMPBELL, Calif.--(BUSINESS WIRE)--Saama Technologies, a leading clinical data analytics company, has launched the Life Science Ecosystem for its partners. The Life Science Ecosystem facilitates complementary and tailored application of its award-winning Life Science Analytics Cloud (LSAC) to customers’ preferred systems and services vendors.
The ecosystem further solidifies the company’s commitment towards its partners to deliver customized solutions focused and developed around their needs. This open partnership combines the unparalleled benefits of Saama’s Life Science Analytics Cloud with the specific strengths and needs of customers’ chosen CROs, clinical or real-world data providers, CTMS and EDC companies, and other technology partners.
Murali Krishnam, Vice President – Strategic Partnerships and Alliances, said, “We always want the best business outcomes for our customers and partners. We understand that most companies are reluctant to go for clinical data analytics transformations, even when there is a dire need for it because they dread the down-time and high price tag that comes attached with it. The learning curve for people to become familiar with new systems is not something that anyone looks forward to either. With our new Life Science Ecosystem, we are offering a way for our customers to leverage our Life Science Analytics Cloud without abandoning their existing infrastructure of vendors and other partners. It is one more way to show that our commitment toward ensuring the success of our partners’ business strategies is inherent in all our offerings.”
The Life Science Analytics Cloud is designed to optimize clinical development processes and deliver outcomes by streamlining the entire process of the clinical data journey. With the Life Science Ecosystem, it becomes that much easier for biopharmaceutical companies to realize clinical outcomes that accelerate product research, development, and commercialization.
“We’re honored to be a part of Saama’s Life Science Ecosystem as we believe that these types of collaborations will be the key to redefining the clinical trial process going forward. By integrating multiple data sources with clinical trial information from our Citeline API’s, clients will be able to make more informed decisions on clinical trial study design, site and investigator selection, and patient enrollment,” said Jason Tse, Head of Strategic Partnerships at Pharma Intelligence/Informa.
To become part of Saama’s Life Science Ecosystem and leverage its state-of-the-art cloud-based clinical data analytics solutions, visit https://www.saama.com/partners/overview/. Saama’s Life Science Analytics Cloud can complement and translate your research, data, systems, and services into better clinical intelligence and patient and business outcomes.
To learn more, visit Saama at booth 316 during this week’s 2018 Summit for Clinical Ops Executives (SCOPE) meeting in Orlando. For insight on leveraging innovative data solutions to optimize clinical trial productivity and outcomes, attend Saama’s “Centralizing Data to Address Imperatives in Clinical Trials” lunch presentation on Wednesday, February 14th at 12:10 pm.
Saama Technologies is the advanced data and analytics company delivering actionable business insights for life sciences and the Global 2000. We are singularly focused on driving fast, flexible, impactful business outcomes for our clients through data and analytics. Our unique “hybrid” approach integrates focused solutions and expertise across the life sciences domain, business consulting, data science, automated data management, and big data technologies. We integrate manual and disconnected initiatives into a well-aligned roadmap facilitating the client’s journey from strategy through solution implementation.
About Informa Pharma Intelligence
Informa Pharma Intelligence powers a full suite of analysis products - Datamonitor Healthcare, Sitetrove, Trialtrove, Pharmaprojects, Medtrack, Biomedtracker, Scrip, Pink Sheet and In Vivo – to deliver the data needed by the pharmaceutical and biomedical industry to make decisions and create real-world opportunities for growth.
With more than 500 analysts keeping their fingers on the pulse of the industry, no key disease, clinical trial, drug approval or R&D project isn’t covered through the breadth and depth of data available to customers. For more information visit pharmaintelligence.informa.com.
Citeline, part of Informa’s Pharma Intelligence vertical, is the world’s most comprehensive source of real-time R&D intelligence for the pharmaceutical industry, featuring an unmatched intelligence collection and enrichment of global clinical trials, clinical trial investigator profiles and drug development pipelines.
Citeline is the R&D Intelligence arm of Informa’s Pharma Intelligence vertical, one of the world’s leading providers of drug, device, company, clinical trial and market intelligence in the pharma and medtech markets. For more information, visit pharmaintelligence.informa.com.